Decatur Capital Management Inc. trimmed its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 28.0% during the third quarter, HoldingsChannel reports. The fund owned 33,045 shares of the healthcare conglomerate’s stock after selling 12,825 shares during the quarter. UnitedHealth Group comprises 1.8% of Decatur Capital Management Inc.’s holdings, making the stock its 14th largest position. Decatur Capital Management Inc.’s holdings in UnitedHealth Group were worth $7,181,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also bought and sold shares of the business. Grove Bank & Trust grew its holdings in UnitedHealth Group by 6.1% during the 1st quarter. Grove Bank & Trust now owns 5,987 shares of the healthcare conglomerate’s stock valued at $1,480,000 after buying an additional 342 shares during the last quarter. Private Capital Group LLC boosted its holdings in shares of UnitedHealth Group by 5.0% during the first quarter. Private Capital Group LLC now owns 5,402 shares of the healthcare conglomerate’s stock worth $1,336,000 after purchasing an additional 258 shares during the last quarter. Access Financial Services Inc. boosted its holdings in shares of UnitedHealth Group by 4.5% during the first quarter. Access Financial Services Inc. now owns 1,740 shares of the healthcare conglomerate’s stock worth $430,000 after purchasing an additional 75 shares during the last quarter. K.J. Harrison & Partners Inc boosted its holdings in shares of UnitedHealth Group by 57.5% during the first quarter. K.J. Harrison & Partners Inc now owns 11,500 shares of the healthcare conglomerate’s stock worth $2,843,000 after purchasing an additional 4,200 shares during the last quarter. Finally, Barber Financial Group Inc. acquired a new stake in shares of UnitedHealth Group during the first quarter worth $203,000. 85.66% of the stock is currently owned by hedge funds and other institutional investors.
Shares of UNH traded up $1.56 during trading hours on Friday, hitting $225.29. The stock had a trading volume of 2,442,725 shares, compared to its average volume of 4,519,363. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.67 and a current ratio of 0.67. The firm has a market cap of $208.59 billion, a P/E ratio of 17.49, a P/E/G ratio of 1.17 and a beta of 0.60. The company’s fifty day simple moving average is $227.48 and its 200 day simple moving average is $240.20. UnitedHealth Group Inc has a 12-month low of $208.07 and a 12-month high of $287.94.
The company also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were given a $1.08 dividend. This represents a $4.32 annualized dividend and a dividend yield of 1.92%. The ex-dividend date of this dividend was Friday, September 13th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 33.54%.
Several research firms have recently issued reports on UNH. ValuEngine upgraded UnitedHealth Group from a “sell” rating to a “hold” rating in a report on Wednesday, October 2nd. Cleveland Research restated a “buy” rating on shares of UnitedHealth Group in a report on Monday, July 15th. Royal Bank of Canada set a $311.00 price objective on UnitedHealth Group and gave the stock a “buy” rating in a report on Friday, July 19th. Oppenheimer set a $312.00 price objective on UnitedHealth Group and gave the stock a “buy” rating in a report on Friday, July 19th. Finally, Jefferies Financial Group cut UnitedHealth Group from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $300.00 to $235.00 in a report on Thursday. Five investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus target price of $283.78.
In related news, Director Richard T. Burke sold 2,500 shares of the stock in a transaction on Tuesday, September 17th. The stock was sold at an average price of $232.76, for a total value of $581,900.00. Following the transaction, the director now directly owns 187,979 shares of the company’s stock, valued at approximately $43,753,992.04. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Timothy Patrick Flynn bought 2,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 28th. The stock was purchased at an average cost of $227.55 per share, for a total transaction of $455,100.00. Following the completion of the transaction, the director now directly owns 5,524 shares in the company, valued at approximately $1,256,986.20. The disclosure for this purchase can be found here. Insiders sold a total of 24,000 shares of company stock worth $5,924,120 over the last ninety days. Corporate insiders own 0.87% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: How is the discount rate different from the Federal Funds rate?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.